NHC director exercises 6,479 stock options
NATIONAL HEALTHCARE CORP (NHC) director David R. Gifford reported an option exercise and related share withholding.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
NATIONAL HEALTHCARE CORP (NHC) director David R. Gifford reported an option exercise and related share withholding. On August 20, 2026, he exercised 6,479 stock options granted under the 2020 Omnibus Equity Incentive Plan at an exercise price of $171.42 per share, receiving 6,479 common shares. In a separate transaction the same day, 4,691 common shares were withheld by the company at $236.75 per share to pay the exercise price. The options were granted on May 7, 2026 and are exempt from Section 16(b) under Rule 16b-3(d).
Insider Trade Summary
6,479 shares exercised/converted
Exercise
3 txns
Insider
Gifford David R.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option to Purchase Common Stock [2026 Grant] F1 | 6,479 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 6,479 | $171.42 | $1.11M |
| Grant/Award | Common Stock F2, F3 | 4,691 | $236.75 | $1.11M |
Holdings After Transaction:
Option to Purchase Common Stock [2026 Grant] — 0 contracts (Direct);
Common Stock — 2,809 shares (Direct)
Footnotes (3)
- F1. These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
- F2. Shares were withheld by the Company to pay the exercise price.
- F3. Total amount of shares beneficially owned following transactions reported on this form.
Key Figures
Options Exercised: 6,479 options
Option Exercise Price: $171.42 per share
Common Shares Acquired: 6,479 shares
+4 more
7 metrics
Options Exercised
6,479 options
Option to Purchase Common Stock [2026 Grant] exercised on August 20, 2026
Option Exercise Price
$171.42 per share
Exercise or conversion price for 6,479 options into common stock
Common Shares Acquired
6,479 shares
Common Stock received from option exercise on August 20, 2026
Shares Withheld to Pay Exercise Price
4,691 shares
Common Stock withheld by the company to pay the option exercise price
Withholding Share Price
$236.75 per share
Price applied to 4,691 withheld shares used to pay the exercise price
Option Grant Date
May 7, 2026
Grant date of options under the 2020 Omnibus Equity Incentive Plan
Option Expiration Date
May 6, 2031
Expiration date for the Option to Purchase Common Stock [2026 Grant]
Key Terms
2020 Omnibus Equity Incentive Plan, Section 16(b), Rule 16b-3(d), beneficially owned
4 terms
2020 Omnibus Equity Incentive Plan financial
"These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan"
Section 16(b) regulatory
"The grant and exercise of these stock options are exempt from Section 16(b)"
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
Rule 16b-3(d) regulatory
"are exempt from Section 16(b) pursuant to Rule 16b-3(d)"
Rule 16b-3(d) is a narrow SEC safe-harbor that shields company insiders (officers, directors and large shareholders) from liability for short‑swing profits when their buys or sells of company stock are made under a pre-established, written plan or contract that removes the insider’s ability to time trades. For investors, this matters because it permits predictable, automated insider transactions — like scheduled sales for diversification or payroll withholding — without triggering forced disgorgement, so such planned trades are treated differently from opportunistic insider trading.
beneficially owned financial
"Total amount of shares beneficially owned following transactions reported"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did NHC director David R. Gifford report?
David R. Gifford exercised 6,479 stock options for NATIONAL HEALTHCARE CORP (NHC) on August 20, 2026 at an exercise price of $171.42 per share, receiving an equal number of common shares, with additional shares withheld to pay the exercise price.
How many NHC stock options did David R. Gifford exercise and at what price?
He exercised 6,479 stock options for NATIONAL HEALTHCARE CORP (NHC) common stock at an exercise price of $171.42 per share, resulting in the acquisition of 6,479 common shares through a derivative exercise transaction.
When were the NHC stock options originally granted to David R. Gifford?
The stock options exercised by David R. Gifford were granted under the 2020 Omnibus Equity Incentive Plan on May 7, 2026, and the grant and exercise are reported as exempt from Section 16(b) under Rule 16b-3(d).
Were David R. Gifford’s NHC transactions under a Rule 10b5-1 trading plan?
No. The document-level Rule 10b5-1 checkbox is marked false, indicating the reported transactions in NATIONAL HEALTHCARE CORP (NHC) shares were not affirmed as being made pursuant to a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates